MedPath
NMPA Approval

Doxofylline Injection

国药准字H20223576

August 10, 2022

Drug Information

多索茶碱注射液

注射剂

20ml:0.2g

化学药品

August 10, 2022

Company Information

Applicant Company

四川省成都市新都区大丰街道蓉北路一段138号

Manufacturing Company

四川绵竹经济开发区江苏工业园镇江路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多索茶碱注射液 - NMPA 批准文号 | MedPath